Hide Board Information

Show Board Information

Nutra Pharma Corp. NPHC

Board Mod: PowerPuncher

Asst Mods:

Last Post: 09/25/2023 12:39:47 PM

Board Marks: 9

Posts Today: 0

Board Views Today: 18

Nutra Pharma Corp. (OTCMRKTS: NPHC) Stock Message Board

1. NPHC Company Profile

    

2. NPHC Time & Sales

    

3. NPHC Recent News

    

4. NPHC Filings

    

5. NPHC Financials

    

6. NPHC Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	Latest Nutra Pharma Corp (NPHC) Headlines Global	Stock_Tracker	03/10/2014 7:41:19 PM
6	NPHC 0.0069 Stock Charts $NPHC 1 Month Chart	chartguy89	03/08/2014 9:33:26 PM
5	NPHC Stock Charts Last: +0.0002 Friday, February	chartguy89	02/28/2014 8:18:17 AM
4	Ready to see some more upside to NPHC.	Atrain	11/27/2012 5:53:19 PM
3	prev analysis still relevant i	PowerPuncher	11/11/2012 6:17:35 AM
2	post split 100% and out on this one. love the	PowerPuncher	09/23/2012 8:55:42 AM
1	Chart shows way oversold even for this guy,	PowerPuncher	03/02/2012 3:02:52 PM

Newer

Recent Articles

• Bragar Eagel & Squire Explores Claims for Anika Stockholders
• Legal Assistance for Western Asset Management Investors
• Investor Alert: Soleno Therapeutics Under Investigation - What to Know
• Cheri Hall Returns to Elevate River Valley Community Bank
• FTAI Aviation Ltd. Announces Presentation at Upcoming Industry Conference
• FG Communities Enhances Growth through Morganton Acquisition
• TEGNA Declares Exciting Quarterly Dividend for Shareholders
• BlackLine to Engage Investors at Annual BeyondTheBlack Event
• Unlocking the Growth Story Behind Constellation Brands Stock
• Investor Concerns Rise as Telix Pharmaceuticals Faces SEC Scrutiny
• Perimeter Medical Imaging AI: Impressive Q2 Results and Future Outlook
• Centene Corporation Investors: Join the Class Action Today
• Waters Corporation's Engaging Participation in Healthcare Events
• EpicQuest Education Completes $3.7 Million Direct Offering
• MIND Technology Sets Schedule for Q2 2026 Earnings Call
• Perimeter Medical Imaging AI Reports Strong Q2 Results and Growth
• Greenwave Technology Solutions Faces Compliance Challenges Ahead
• TXNM Energy Announces Quarterly Preferred Dividend Details
• FTAI Aviation Ltd. Excited for Upcoming Industry Conference
• Commercial Metals Company Celebrates Arts Education Excellence
• TEGNA Inc. Declares Quarterly Dividend for Shareholders
• Insight Molecular Diagnostics: Upcoming NYC Investor Conferences
• BlackLine's Upcoming Investor Session at BeyondTheBlack 2025
• Zentalis Pharmaceuticals Strengthens Leadership with New CLO
• SRx Health Solutions Addresses Late Filing Notification from NYSE
• Seer, Inc. Set to Shine at Major Healthcare Conference Soon
• nCino Delivers Stellar Q2 Fiscal 2026 Performance Report
• Sana Biotechnology Schedules September Investor Presentations
• NovaBay Pharmaceuticals Declares $0.80 Special Dividend for Shareholders
• Vera Therapeutics Announces Participation in Key Investor Events
• Sight Sciences to Shine at the Morgan Stanley Conference
• Pulmonx Corporation's Upcoming Investor Engagements Revealed
• Understanding Nasdaq's Mid-Month Open Short Interest Trends
• Could SoFi Technologies Be the Next Breakthrough Investment?
• StepStone Group's Upcoming Presentation: Insights and Strategies
• Zentalis Pharmaceuticals Welcomes James B. Bucher as CLO
• IRADIMED CORPORATION: Key Insights from Upcoming Conference
• 3D Systems Secures $7.65 Million for Groundbreaking Printer Tech
• Consumer Portfolio Services Set to Shine at Upcoming Conference
• Pulmonx Corporation Gears Up for Key September Investor Events
• Immuneering Corp Secures $25 Million in Recent Financing Round
• NovaBay Pharmaceuticals Declares Exciting Special Cash Dividend
• IRADIMED CORPORATION Set to Shine at 2025 Healthcare Event
• Phillips Edison & Company Geared Up for Upcoming Real Estate Event
• Calavo Growers Set to Publish Q3 Financial Performance Insights
• MYR Group Welcomes Aurelie Richard to Board of Directors
• Immuneering Secures $25 Million Investment to Advance Oncology Solutions
• Key Insights from LifeStance's Upcoming Conference Participation
• Insight Molecular Diagnostics Set for NYC Investor Engagements
• Investigation Updates for Key Companies: What You Need to Know